Safe Harbour

Safe Harbour is a SAMHSA-registered addiction-treatment facility in Owatonna, MN. The facility offers specific levels of care: Inpatient, MAT. This page frames the questions that matter most when evaluating a specific program — the ones that separate useful candidates from marginal ones.

Care levels at Safe Harbour

On care levels: The facility's documented care levels are The facility offers specific levels of care: Inpatient, MAT. — each of which is appropriate for specific clinical presentations. Matching the level to the specific clinical need is the pre-admission work. The critical pre-admission step is an independent clinical assessment that establishes ASAM 4e level-of-care recommendation. Admission at a facility whose offered level does not match the clinical assessment produces most misaligned-placement outcomes.

Insurance and payment

Safe Harbour accepts Medicaid — which is consequential because facilities that accept Medicaid tend to have the broadest patient populations and the most developed public-sector relationships, though reimbursement structures mean program intensity sometimes differs from commercial-focused centers. Before admission, request a written Verification of Benefits from the facility's utilization-review team. Verbal VOB is where most post-admission cost-sharing disputes originate. Written documentation settles them.

Specialty programming

The facility's documented specialty programming includes: Clients with co-occurring mental and substance use disorders, Clients who have experienced trauma, Persons with post-traumatic stress disorder (PTSD). Evaluating specialty capacity requires asking specifically: what clinicians deliver the specialty content, with what credentials, for how many hours per week. Marketing designation without documented clinical infrastructure is a recognized pattern worth filtering out.

Before you call

Three pre-admission questions for Safe Harbour: (1) at what ASAM 4e level are you admitting me, and what is the clinical rationale; (2) can you provide written Verification of Benefits for my specific plan; (3) what is your MAT policy for opioid use disorder — specifically, do you continue buprenorphine or methadone during residential programming. The facility's documented pharmacotherapy offerings suggest MAT is available — confirm the specific medications and prescriber access during the admissions conversation.